Abstract
In patients with familial lipoprotein lipase deficiency (FLPL-d) and glycogen storage disease type I (GSD-I), hypertriglyceridaemia (1445 +/- 247 and 1082 +/- 312 mg dl-1, n = 5 per group) was associated primarily with reduced extrahepatic lipoprotein lipase (LPL) activity (0.33 +/- 0.33 and 1.69 +/- 0.38 mumol FFA ml-1 h-1) when compared with controls (4.83 +/- 0.90). Hypercholesterolaemia was characterized by elevated LDL cholesterol (191 +/- 30 and 344 +/- 34 vs. 115 +/- 5 mg dl-1 in controls P less than 0.01) and low HDL cholesterol (12 +/- 2 and 22 +/- 2 vs. 56 +/- 3 in controls, P less than 0.001). In order to ascertain the role of LPL in the interconversion and remodelling of lipoproteins in these disorders, we analysed lipid and lipoprotein profiles before and following in vitro incubation of patient plasma with purified milk LPL (EC 3.1.1.34) for 6 h at 37 degrees C. The efficiency of exogenous LPL in vitro was demonstrated by the extent of hydrolysis of chylomicrons and of VLDL-TG in both groups. Concomitant with the disappearance of TG-rich lipoprotein particles, a consistent per cent increment of IDL (99.2 +/- 30.8 and 43.9 +/- 70.5), LDL (152.8 +/- 36.2 and 137.0 +/- 36.1) and of HDL2 (144.8 +/- 29.4 and 99.8 +/- 1...Continue Reading
References
Jan 4, 1975·Lancet·G J Miller, N E Miller
Nov 1, 1977·Atherosclerosis·A K SoutarG R Thompson
Feb 1, 1978·Atherosclerosis·D W AndersonF T Lindgren
Apr 1, 1978·Atherosclerosis·E A NikkiläM Kekki
Sep 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·J R PatschS Eisenberg
Nov 30, 1978·The New England Journal of Medicine·A R Tall, D M Small
Mar 1, 1979·Atherosclerosis·A K SoutarG R Thompson
Jan 1, 1986·Methods in Enzymology·S Eisenberg
Feb 1, 1987·American Heart Journal·W C Breckenridge
Feb 28, 1986·Biochimica Et Biophysica Acta·K A Rye, P J Barter
Jul 9, 1985·Biochimica Et Biophysica Acta·G KnippingA Holasek
Dec 20, 1973·Biochimica Et Biophysica Acta·S EisenbergF T Lindgren
Nov 1, 1974·The Journal of Clinical Investigation·R M KraussD S Fredrickson
Nov 1, 1969·The Journal of Clinical Investigation·D S FredricksonF T Lindgren
Mar 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·J R PatschA M Gotto
Sep 12, 1984·Biochimica Et Biophysica Acta·K A Rye, P J Barter
Sep 1, 1983·Atherosclerosis·Y C HaP J Barter
Feb 1, 1981·European Journal of Clinical Investigation·N E MillerB Lewis
May 1, 1982·Metabolism: Clinical and Experimental·F C BallantyneD Ballantyne
Jan 1, 1980·Annual Review of Biochemistry·P Nilsson-EhleM C Schotz
Feb 1, 1982·Atherosclerosis·M R TaskinenR L Jackson
Mar 12, 1982·Clinica Chimica Acta; International Journal of Clinical Chemistry·G SchmitzB Melnik
Oct 14, 1982·Biochimica Et Biophysica Acta·P GambertP Padieu
Citations
Sep 21, 2010·The Journal of Biological Chemistry·Kalyani G BharadwajIra J Goldberg
Feb 10, 1999·The American Journal of Physiology·M ZoltowskaE Levy
Apr 13, 2013·Human Gene Therapy·John J P KasteleinMichael R Hayden
Apr 15, 1996·Thrombosis Research·K KeddadA Legrand
Feb 1, 1996·Clinical Biochemistry·K KeddadA Legrand
Mar 1, 1995·Atherosclerosis·K C TanD J Betteridge
Jan 17, 1996·Biochimica Et Biophysica Acta·K KeddadA Legrand
Jun 6, 1994·The American Journal of Medicine·D J Betteridge
Jun 1, 1997·Metabolism: Clinical and Experimental·R M FisherS W Coppack
Jul 28, 2009·Atherosclerosis·Dacheng PengShutsung Liao